Company intelligence / Profile preview

SK Inc.

Seoul, South Korea

Ownership: Private
Employees: ~716
Development stage: Other

Overview

SK Inc. is the flagship holding company of South Korea's SK Group and also operates a substantial IT services and digital transformation business historically associated with SK C&C. The company invests across advanced materials, biopharmaceuticals, green energy, and digital businesses, while its operating business provides enterprise IT, cloud, AI, system integration, and digital factory solutions. Although SK Inc. has exposure to healthcare through portfolio companies such as SK Biopharmaceuticals and SK Pharmteco, SK Inc. itself is not a biotech, pharma, or healthcare operating company. The requested name "SK Holdings C&C" appears to refer to the legacy or alternate naming around SK C&C/SK Holdings prior to and following the 2015 merger that formed the current SK Inc.

Industry: Investors

Beyond the preview

Go deeper on SK Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SK Inc..

Explore the full profile